- Home
- ALHC
as 10-24-2025 3:52pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Upcoming Earnings Alert:
Get ready for potential market movements as Alignment Healthcare Inc. ALHC prepares to release earnings report on 30 Oct 2025.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 2.7B | IPO Year: | 2021 |
| Target Price: | $18.50 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.18 - $21.06 | Next Earning Date: | 10-30-2025 |
| Revenue: | $3,335,894,000 | Revenue Growth: | 49.46% |
| Revenue Growth (this year): | 47.21% | Revenue Growth (next year): | 28.24% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| KAO JOHN E | ALHC | Chief Executive Officer | Oct 10 '25 | Sell | $17.29 | 180,000 | $3,111,480.00 | 2,706,726 | |
| Kim Hyong | ALHC | Chief Medical Officer | Oct 9 '25 | Sell | $17.57 | 51,379 | $902,795.82 | 362,333 | |
| Kim Hyong | ALHC | Chief Medical Officer | Oct 8 '25 | Sell | $17.29 | 33,655 | $581,894.95 | 362,333 | |
| GENERAL ATLANTIC, L.P. | ALHC | Director, 10% Owner | Sep 17 '25 | Sell | $16.01 | 6,246,096 | $99,999,996.96 | 24,596,079 | |
| General Atlantic (ALN HLTH), L.P. | ALHC | Director, 10% Owner | Sep 17 '25 | Sell | $16.01 | 6,246,096 | $99,999,996.96 | 24,596,079 | |
| KONOWIECKI JOSEPH S | ALHC | Director | Sep 16 '25 | Sell | $16.24 | 16,076 | $261,074.24 | 1,110,973 | |
| GENERAL ATLANTIC, L.P. | ALHC | Director, 10% Owner | Sep 12 '25 | Sell | $16.01 | 13,460,000 | $215,494,600.00 | 24,596,079 | |
| General Atlantic (ALN HLTH), L.P. | ALHC | Director, 10% Owner | Sep 12 '25 | Sell | $16.01 | 13,460,000 | $215,494,600.00 | 24,596,079 | |
| Scavo Robert L. | ALHC | Chief Information Officer | Sep 10 '25 | Sell | $16.54 | 29,535 | $484,599.97 | 580,967 | |
| KAO JOHN E | ALHC | Chief Executive Officer | Sep 10 '25 | Sell | $16.50 | 535,018 | $8,779,960.71 | 2,706,726 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
BrightSpring Health Services, Inc. (BTSG) Tops Q3 Earnings and Revenue Estimates
Simply Wall St.
21 days ago
A Look at Alignment Healthcare’s (ALHC) Valuation Following 2026 Medicare Advantage Expansion Announcement
TipRanks
23 days ago
Alignment Healthcare announces its 2026 product portfolio
GlobeNewswire
23 days ago
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
GlobeNewswire
24 days ago
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
GlobeNewswire
2 months ago
Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy
MT Newswires
2 months ago
Alignment Healthcare Insider Sold Shares Worth $396,800, According to a Recent SEC Filing
StockStory
2 months ago
3 Growth Stocks to Stash
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.